DocuSign Inc. (NASDAQ: DOCU) was raised to Buy from Hold at Deutsche Bank. Shares closed up 2% at $52.66 and had a consensus target price of $57.70 ahead of this call.
First Data Corp. (NYSE: FDC) was downgraded to Market Perform from Outperform at Wells Fargo.
Ford Motor Co. (NYSE: F) was started with a Neutral rating at Seaport Global. Ford closed up 1.56% at $8.46 on Tuesday, in a 52-week range of $7.41 to $12.15 and with a consensus analyst target of $9.32.
Freeport-McMoRan Inc. (NYSE: FCX) was raised to Overweight from Equal Weight at Morgan Stanley, but the firm lowered its price target to $14 from $16.
Galectin Therapeutics Inc. (NASDAQ: GALT) was started with a Buy rating and assigned an $11 price target (versus a $4.46 close) at B. Riley FBR. It has only a $200 million market cap, and its 52-week trading range is $3.10 to $9.49.
General Motors Co. (NYSE: GM) was started with a Buy rating at Seaport Global. GM shares closed up 1% at $39.03 on Tuesday, in a 52-week range of $30.56 to $45.00 and with a consensus target price of $45.45.
Geron Corp. (NASDAQ: GERN) was started with a Buy rating and assigned a $4 target price (versus a $1.31 close) at BTIG Research. The stock was indicated up 14% at $1.50 after the call, in a 52-week range of $0.95 to $6.99.
Globant S.A. (NYSE: GLOB) was reiterated as Outperform and the price target was raised to $75 from $65 (versus a $68.00 close) at Wedbush. The firm noted that the company’s results are expected to benefit from a combination of ongoing expansion of digital-related project sizes and currency exchange tailwinds.
HubSpot Inc. (NYSE: HUBS) was up 2.6% at $172.00 on Tuesday’s post-earnings reaction. Merrill Lynch reiterated its Buy rating and raised its price objective to $205 from $185 (versus a $172.00 close). The firm noted that enterprise strength is driving up billings and upside to average selling prices with multiple product sales momentum in 2019.
Huntsman Corp. (NYSE: HUN) was downgraded to Neutral from Overweight at JPMorgan.
Lattice Semiconductor Corp. (NASDAQ: LSCC) was raised to Positive from Neutral at Susquehanna. Its shares were up 2.9% at $8.18 ahead of earnings but were last seen trading up 19% at $9.75 after earnings.
Ligand Pharmaceuticals Inc. (NASDAQ: LGND) was maintained as Buy at Argus, but the firm lowered its target price to $150 from $200. The independent research firm noted that recent weakness offers a buying opportunity as the company is believed to be on track to post solid earnings growth over the next several years. The stock closed up 1.5% at $119.76 on Tuesday, in a 52-week range of $98.56 to $278.62 a share.
Medical Properties Trust Inc. (NYSE: MPW) was raised to Buy from Hold and the price target was raised to $23 from $18 (versus an $18.15 close) at Jefferies. The 52-week range is $12.20 to $18.56, and the consensus target price is $16.27.